• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Novartis AG Common Stock (NY:NVS)

    140.28 -0.78 (-0.55%)
    Delayed Quote Updated: 12:45 PM EDT, Oct 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Novartis AG Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    At the Longevity Investors Conference in Gstaad, Investors Test Which Longevity Claims Hold Up
    DATELINE]As longevity research moves from animal models into human trials, investors are asking a sharper question: what is science, and... 
    Via Newsfile
    News headline image
    Leaders Face Stark Warning from Silicon Valley Veteran – The Old Way of Working is Dead
    Via Get News
    Topics Artificial Intelligence
    MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
    Via Investor Brand Network
    Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
    Via Investor Brand Network
    MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
    Via Investor Brand Network
    News headline image
    2025 R&D Spending And Intensity Benchmarks
    Via PRLog
    Topics Supply Chain
    News headline image
    Hear from a prostate cancer patient about the one test more men should ask for
    (Novartis) - Dr. Koo, EVP and CMO at Prostate Cancer Foundation, and Bill, who is living with prostate cancer, answer some frequently asked questions about PSMA testing. Talk to your doctor and visit... 
    Via NewsUSA
    News headline image
    Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
    From BioMedWire
    Via GlobeNewswire
    News headline image
    StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data
    New report covers Nuvectis Pharma (NASDAQ: NVCT) as the company transitions from a single-drug oncology story into a late-stage rare-disease... 
    Via Newsfile
    MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5 Billion ADC Acquisition
    Via Investor Brand Network
    News headline image
    Core Restore Founder Ann Peets Announces Bladder Leak Treatments In Charleston
    Via Press Release Distribution Service
    The Quest to Repair What Multiple Sclerosis Takes Away
    Via Investor Brand Network
    InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis
    Via Investor Brand Network
    News headline image
    The Quest to Repair What Multiple Sclerosis Takes Away
    From BioMedWire
    Via GlobeNewswire
    Veteran Biopharma Engineer Ge Yang Attracts Investor Interest with Vision to Redefine Global Pharma Manufacturing
    Via AB Newswire
    News headline image
    Bionique Wins Dual Golds for “Exosome + Probiotic” Breakthrough in Women’s Microbiome Health
    Via Get News
    Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For
    Via Investor Brand Network
    News headline image
    BIOCHINA2026 – Fusion Forward: Uniting the Global Biopharma Community in Suzhou
    Via Press Release Distribution Service
    News headline image
    Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For
    From BioMedWire
    Via GlobeNewswire
    News headline image
    BIOCHINA2026 – Fusion Forward: Uniting the Global Biopharma Community in Suzhou
    Via Get News
    Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
    Via Investor Brand Network
    News headline image
    Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
    EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOBT),(NYSE:NVS),(NASDAQ:BCAX),(NYSE:PFE) EQNX::TICKER_END 
    Via FinancialNewsMedia
    News headline image
    Digital Pharma Advances 2026: AI and Patient-Centric Strategies Transform Pharma Marketing
    Via PRLog
    Topics Artificial Intelligence
    News headline image
    2024 R&D Spending and Intensity Benchmarks
    Via PRLog
    Topics Supply Chain
    News headline image
    Gateway to Growth: Innovation and Opportunity at the 8th CIIE
    Via Press Release Distribution Service
    Topics Economy
    News headline image
    Gateway to Growth: Innovation and Opportunity at the 8th CIIE
    Via Get News
    Topics Economy
    News headline image
    Hazelden Betty Ford Foundation Appoints Four New Members to Its Board of Trustees
    Center City, Minnesota--(Newsfile Corp. - July 31, 2025) - Hazelden Betty Ford Foundation, the nation's leading nonprofit system of addiction... 
    Via Newsfile
    News headline image
    15 regions chosen for groundbreaking effort to reduce cardiovascular disease
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    News headline image
    Screening for cardiovascular disease marker in community health centers may reduce risk
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.